KIDS - NASDAQ

OrthoPediatrics Corp.

KIDS·NASDAQ

$16.92

+0.65%

HealthcareMedical - Devices

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$434.59M

EPS-1.6900

P/E Ratio-10.01

Earnings Date08/04/2026

508.63M

Assets

3Y+19.0%

5Y+57.0%

10Y+1558.0%

162.03M

Total Liabilities

37%

3Y+230.0%

5Y+80.0%

10Y+556.0%

346.60M

Total Equity

-2%

3Y-8.0%

5Y+48.0%

10Y+5682.0%

OrthoPediatrics Corp. Funding & Solvency Profile

KIDS · NASDAQ

Current Assets

Cash & Cash Equivalents19.56M

Net Receivables53.84M

Inventory133.79M

Other Current Assets7.94M

Total Current Assets256 M

Non-Current Assets

Property, Plant & Equipment49.55M

Goodwill & Intangible Assets186.98M

Long-Term Investments0.00

Other Non-Current Assets15.68M

Total Non-Current Assets65 M

Total Assets

508.63M

Financial Health Analysis

Current Ratio

5.55x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.47x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

210 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

50% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

OrthoPediatrics Corp. Balance Sheet

KIDS • NASDAQ

OrthoPediatrics Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	19.6M	43.8M	31.1M	9M	9M	30.1M	70.8M	60.7M	42.6M	1.6M	3.9M	6.6M
Short-Term Investments	41.3M	25M	49.3M	109.3M	45.9M	55.1M	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	60.9M	68.8M	80.3M	118.3M	54.9M	85.3M	70.8M	60.7M	42.6M	1.6M	3.9M	6.6M
Net Receivables	53.8M	42.4M	34.6M	24.8M	17.9M	17.5M	16.6M	9.5M	5.6M	4.1M	3.8M	2.8M
Accounts Receivables	53.8M	42.4M	34.6M	24.8M	17.9M	17.5M	16.6M	9.5M	5.6M	4.1M	3.8M	2.8M
Inventory	133.8M	117M	105.9M	78.2M	57.6M	53M	38M	25.7M	20.5M	14.9M	14.6M	17.3M
Prepaids	0.0	7M	0.0	4M	0.0	0.0	1.5M	1.3M	831K	233K	222K	252K
Other Current Assets	7.9M	2M	5.7M	1.5M	3.2M	2.6M	1.3M	0.0	831K	233K	0.0	577K
Total Current Assets	256.4M	237.2M	226.5M	226.7M	133.6M	158.4M	128.1M	97.2M	69.6M	20.8M	22.5M	27.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	49.6M	58.8M	41M	34.3M	28.5M	27.2M	21.3M	12.8M	10.4M	8.6M	7.3M	7.5M
Goodwill	109.3M	93.8M	83.7M	86.8M	72.3M	70.5M	26.2M	0.0	0.0	0.0	0.0	0.0
Intangible Assets	77.7M	81.2M	84.6M	79.9M	69.8M	64.2M	19M	2.2M	2.3M	1.3M	887K	852K
Goodwill & Intangible Assets	187M	175M	168.3M	166.7M	142.1M	134.8M	45.2M	2.2M	2.3M	1.3M	887K	852K
Long-Term Investments	0.0	2.2M	1.9M	189.5M	0.0	0.0	53.3M	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	0.0	0.0	6M	4.1M	4.4M	832K	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	15.7M	0.0	1.1M	-195.5M	0.0	0.0	-54.1M	0.0	0.0	0.0	0.0	0.0
Total Non-Current Assets	252.2M	236M	212.2M	201M	174.8M	166.4M	66.5M	14.9M	12.7M	9.9M	8.2M	8.3M
Total Assets	508.6M	473.2M	438.7M	427.7M	308.4M	324.8M	194.6M	112.1M	82.3M	30.7M	30.7M	35.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	21M	8.9M	22.8M	11.2M	9.3M	10M	6.5M	4M	5.5M	3.5M	2M	645K
Accounts Payable	18.8M	8.9M	12.6M	11.2M	9.3M	10M	6.5M	4M	5.5M	3.5M	2M	645K
Other Payables	2.2M	0.0	10.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	8.4M	13.9M	11.3M	6.7M	5.4M	4.5M	4.3M	3.6M	2.9M	2.2M	2.3M	1.5M
Short Term Debt	170K	160K	152K	144K	13M	12.4M	124K	118K	113K	107K	101K	97K
Capital Lease Obligations (Current)	0.0	2.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	6M	0.0	0.0	4.3M	3.6M	2.9M	2.2M	2.3M	1.5M
Other Current Liabilities	16.6M	8.9M	7.4M	6.9M	2M	8.1M	-1.6M	1.6M	954K	1.4M	2M	992K
Total Current Liabilities	46.2M	34M	41.7M	30.9M	29.7M	35M	13.7M	9.2M	9.5M	7.3M	6.3M	3.2M
NON-CURRENT LIABILITIES
Long Term Debt	99.8M	73M	9.9M	763K	15.2M	13.8M	26.1M	21.2M	25.3M	17.4M	13M	13.1M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	12.4M	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	3.6M	0.0	5.5M	6M	8.9M	10.2M	-63K	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	12.4M	6.1M	4.7M	11.5M	28.9M	30.7M	0.0	0.0	0.0	0.0	0.0	1.5M
Total Non-Current Liabilities	115.8M	84.7M	20.1M	18.2M	53.3M	55M	38.5M	21.2M	25.3M	17.4M	13M	14.6M
Capital Lease Obligations	0.0	7.8M	0.0	0.0	293K	323K	63K	0.0	0.0	0.0	0.0	0.0
Total Liabilities	162M	118.6M	61.7M	49.1M	83M	90.1M	52.2M	30.4M	34.8M	24.7M	19.4M	17.9M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.3M	71.3M	65.4M	60.6M
Common Stock	6K	6K	6K	6K	5K	5K	4K	4K	2K	1K	1K	1K
Additional Paid-In Capital	622.3M	600.9M	580.3M	560.8M	394.9M	388.6M	271.2M	197.4M	150.4M	12.8M	17.4M	21M
Retained Earnings	-275.2M	-235.6M	-197.7M	-176.8M	-178M	-161.8M	-128.8M	-115.1M	-103.1M	-78.1M	-71.6M	-63.7M
Accumulated Other Comprehensive Income/Loss	-523K	-10.8M	-5.5M	-5.4M	8.5M	7.9M	-3K	-623K	135K	0.0	-6.2M	-4.4M
Total Stockholders' Equity	346.6M	354.6M	377M	378.6M	225.4M	234.8M	142.4M	81.7M	47.5M	6M	11.3M	18M
Total Equity	346.6M	354.6M	377M	378.6M	225.4M	234.8M	142.4M	81.7M	47.5M	6M	11.3M	18M
SUMMARY
Total Liabilities & Equity	508.6M	473.2M	438.7M	427.7M	308.4M	324.8M	194.6M	112.1M	82.3M	30.7M	30.7M	35.8M
Total Investments	41.3M	27.2M	51.1M	298.8M	45.9M	55.1M	53.3M	0.0	0.0	0.0	0.0	0.0
Total Debt	100M	80.9M	10.1M	907K	28.5M	26.5M	26.3M	21.3M	25.5M	17.5M	13.1M	13.2M
Net Debt	80.4M	37.1M	-21M	-8.1M	19.5M	-3.6M	-44.5M	-39.4M	-17.1M	15.9M	9.3M	6.7M
Shares Outstanding	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324	25,077,324

SEC Filings

KIDS - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 01, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 20, 2026	April 20, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 01, 2026	March 31, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 04, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing

Showing 1 to 10 of 205 filings

Related Guides

Blog Categories

Continue your KIDS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.